decisionhealth Newsletters, Answer Books - 2011 Issue 1 (January)
Opioid Management / Urine drug screens
Subscribe or sign in to view the full article.
Article Overview
This article explains urine drug screen billing in opioid management settings and highlights the shift in reporting guidance that accompanied CPT and CMS updates effective January 1, 2011. It is relevant to clinicians, billing staff, and coding professionals who need a high-level understanding of the applicable code sets, Medicare coverage context, and documentation considerations discussed for point-of-care testing.
Why This Topic Matters
Urine drug screening is commonly used in opioid monitoring, but reimbursement depends on payer-specific documentation and the correct code set selection. The article helps readers understand the general scope of the coding changes and the Medicare-related constraints that affect claim submission.
What You Will Learn
- How urine drug screen reporting is discussed in opioid management contexts
- What types of coding and billing updates were introduced for 2011
- How the article frames Medicare and CMS considerations for in-office testing
- Why documentation and test complexity are part of the billing discussion
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Pain management practices
- Primary care practices
- Laboratory staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com